← Back to Search

Backwards Walking Group (BWG) for Multiple Sclerosis

N/A
Waitlist Available
Research Sponsored by Mount Sinai Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in f baseline gait speed (timed 25 foot walk) after 8 week intervention
Awards & highlights
No Placebo-Only Group

Summary

There have been no published studies to date on the effects of backwards walking in persons with MS. Thus it is important that the investigators explore different methods for treatment to help improve balance and gait and prevent injury in persons with MS with gait disturbances and balance impairments.The overall goal of this research is to collect pilot data on the effectiveness of backwards walking as a therapy for improving spatiotemporal, clinical gait and balance assessments in persons with Multiple Sclerosis compared to forward walking.

Eligible Conditions
  • Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in baseline spatiotemporal walking parameters from gaitrite mat after 8 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in baseline spatiotemporal walking parameters from gaitrite mat after 8 week intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Gait Speed (Timed 25 Foot Walk)
Spatiotemporal Walking Parameters from Gaitrite Mat

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Backwards Walking Group (BWG)Experimental Treatment1 Intervention
The intervention will consist of three (3), treadmill exercise sessions per week, for eight (8) weeks, for a total of 24 exercise sessions.
Group II: Forwards Walking Group (FWG)Active Control1 Intervention
The intervention will consist of three (3), treadmill exercise sessions per week, for eight (8) weeks, for a total of 24 exercise sessions.

Find a Location

Who is running the clinical trial?

National Multiple Sclerosis SocietyOTHER
97 Previous Clinical Trials
9,648 Total Patients Enrolled
95 Trials studying Multiple Sclerosis
9,294 Patients Enrolled for Multiple Sclerosis
Mount Sinai Rehabilitation HospitalLead Sponsor
6 Previous Clinical Trials
729 Total Patients Enrolled
5 Trials studying Multiple Sclerosis
369 Patients Enrolled for Multiple Sclerosis
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top